Olipudase alfa, sold under the brand name Xenpozyme, is a medication used for the treatment of non-central nervous system (CNS) manifestations of acid...
13 KB (952 words) - 02:34, 12 October 2024
approving it in the United States for Niemann-Pick type C disease. Olipudase alfa (Xenpozyme) was approved for medical use in Japan in March 2022. Arimoclomol...
30 KB (3,169 words) - 04:58, 25 September 2024
A16AB23 Cipaglucosidase alfa A16AB24 Pegzilarginase A16AB25 Olipudase alfa A16AB26 Eladocagene exuparvovec A16AB27 Pabinafusp alfa A16AX01 Thioctic acid...
3 KB (358 words) - 02:46, 18 December 2023
Pemigatinib Incyte myeloid/lymphoid neoplasms with FGFR1 rearrangement Olipudase alfa Genzyme non–central nervous system manifestations of acid sphingomyelinase...
34 KB (180 words) - 22:09, 8 April 2024